The contribution of maternal HIV seroconversion during late pregnancy and breastfeeding to mother-to-child transmission of HIV

Journal of Acquired Immune Deficiency Syndromes

Volumn 59, Issue 4, 2012, Pages 417-425

  Johnson, Leigh F ^a   Stinson, Kathryn ^a   Newell, Marie Louise ^b,c   Bland, Ruth M ^b,d   Moultrie, Harry ^e,f   Davies, Mary Ann ^a   Rehle, Thomas M ^a,g   Dorrington, Rob E ^h   Sherman, Gayle G ^f,i  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b UNIVERSITY OF KWAZULU NATAL   (South Africa)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY OF GLASGOW   (United Kingdom)

^e UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^f UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^g HUMAN SCIENCES RESEARCH COUNCIL   (South Africa)

^h UNIVERSITY OF CAPE TOWN   (South Africa)

ⁱ NATIONAL HEALTH LABORATORY SERVICE   (South Africa)

Author keywords

HIV AIDS; Mathematical model; South Africa; Vertical transmission

Indexed keywords

NEVIRAPINE; ZIDOVUDINE;

AGE; ANTIVIRAL THERAPY; ARTICLE; BREAST FEEDING; CHEMOPROPHYLAXIS; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INCIDENCE; INFANT; INFECTION PREVENTION; MATHEMATICAL MODEL; PATIENT COUNSELING; PRIORITY JOURNAL; SEROCONVERSION; SINGLE DRUG DOSE; SOUTH AFRICA; THIRD TRIMESTER PREGNANCY; VERTICAL TRANSMISSION; VIRUS TRANSMISSION;

ADOLESCENT; ADULT; BREAST FEEDING; CHILD; FEMALE; HIV INFECTIONS; HIV SEROPOSITIVITY; HUMANS; INCIDENCE; INFANT, NEWBORN; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; MALE; MODELS, BIOLOGICAL; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREVALENCE; SOUTH AFRICA;

EID: 84859753234     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0b013e3182432f27     Document Type: Article

References (83)

1. Sperling RS, Shapiro DE, Coombs RW, et al. Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant. N Engl J Med. 1996;335:1621-1629. (Pubitemid 26392726)
2. Farquhar C, Mbori-Ngacha D, Overbaugh J, et al. Illness during pregnancy and bacterial vaginosis are associated with in-utero HIV-1 transmission. AIDS. 2010;24:153-155.
3. Taha TE, Kumwenda NI, Hoover DR, et al. Nevirapine and zidovudine at birth to reduce perinatal transmission of HIV in an African setting: a randomized controlled trial. JAMA. 2004;292:202-209. (Pubitemid 38917997)
4. Rousseau CM, Nduati RW, Richardson BA, et al. Association of levels of HIV-1-infected breast milk cells and risk of mother-to-child transmission. J Infect Dis. 2004;190:1880-1888. (Pubitemid 39487835)
5. Pillay K, Coutsoudis A, York D, et al. Cell-free virus in breast milk of HIV-1-seropositive women. J Acquir Immun Defic Syndr. 2000;24:330-336.
6. Barin F, Jourdain G, Brunet S, et al. Revisiting the role of neutralizing antibodies in mother-to-child transmission of HIV-1. J Infect Dis. 2006; 193:1504-1511. (Pubitemid 43794578)
7. Van de Perre P, Simonon A, Hitimana DG, et al. Infective and antiinfective properties of breastmilk from HIV-1-infected women. Lancet. 1993;341:914-918. (Pubitemid 23109109)
8. Koopman JS, Jacquez JA, Welch GW, et al. The role of early HIV infection in the spread of HIV through populations. J Acquir Immun Defic Syndr. 1997;14:249-258.
9. Hyman JM, Li J, Stanley EA. The differential infectivity and staged progression models for the transmission of HIV. Math Biosci. 1999; 155:77-109. (Pubitemid 129672419)
10. Abu-Raddad LJ, Longini IM Jr. No HIV stage is dominant in driving the HIV epidemic in sub-Saharan Africa. AIDS. 2008;22:1055-1061. (Pubitemid 351769744)
11. Dube S, Boily MC, Mugurungi O, et al. Estimating vertically acquired HIV infections and the impact of the prevention of mother-to-child transmission program in Zimbabwe: insights from decision analysis models. J Acquir Immun Defic Syndr. 2008;48:72-81. (Pubitemid 351600857)
12. Lu L, Legwaila K, Motswere C, et al. HIV incidence in pregnancy and the first post-partum year and implications for PMTCT programs, Francistown, Botswana, 2008 [Abstract 91]. Presented at: 16th Conference on Retroviruses and Opportunistic Infections; Feb 8-11, 2009; Montreal, Canada.
13. Soorapanth S, Sansom S, Bulterys M, et al. Cost-effectiveness of HIV rescreening during late pregnancy to prevent mother-to-child HIV transmission in South Africa and other resource-limited settings. J Acquir Immun Defic Syndr. 2006;42:213-221. (Pubitemid 43884717)
14. Dorrington RE, Johnson LF, Bradshaw D, et al. The Demographic Impact of HIV/AIDS in South Africa. National and Provincial Indicators for 2006. Cape Town, South Africa: Centre for Actuarial Research, South African Medical Research Council and Actuarial Society of South Africa; 2006. Available at: http://www.commerce.uct.ac.za/care. AccessedAugust 3, 2011.
15. Johnson LF, Dorrington RE. Modelling the demographic impact of HIV/AIDS in South Africa and the likely impact of interventions. Demographic Res. 2006;14:541-574. (Pubitemid 43994815)
16. Department of Health. South Africa Demographic and Health Survey 1998: Full Report. Available at: http://www.measuredhs.com/publications/publication- fr131-dhs-final-reports.cfm. Accessed January 6, 2012.
17. Moodley D, Esterhuizen TM, Pather T, et al. High HIV incidence during pregnancy: compelling reason for repeat HIV testing. AIDS. 2009;23: 1255-1259.
18. Jackson DJ, Chopra M, Doherty TM, et al. Operational effectiveness and 36 week HIV-free survival in the South African programme to prevent mother-to-child transmission of HIV-1. AIDS. 2007;21:509-516.
19. Lindbäck S, Thorstensson R, Karlsson A, et al. Diagnosis of primary HIV-1 infection and duration of follow-up after HIV exposure. AIDS. 2000;14:2333-2339.
20. Tovo PA, Palomba E, Gabiano C, et al. Human immunodeficiency virus type 1 (HIV-1) seroconversion during pregnancy does not increase the risk of perinatal transmission. Br J Obstet Gynaecol. 1991;98:940-942.
21. Rudin C, Lauper U, Biedermann K. HIV seroconversion during pregnancy [Abstract W.C.3247]. Presented at: 7th International AIDS Conference; June 16-21, 1991; Florence, Italy.
22. Hague RA, Mok JY, Johnstone FD, et al. Maternal factors in HIV transmission. Int J STD AIDS. 1993;4:142-146. (Pubitemid 23161756)
23. Nielsen-Saines K, Melo M, Varella I, et al. Primary HIV-1 infection during pregnancy: high rate of HIV-1 MTCT in a cohort of patients in southern Brazil. Retrovirology. 2008;5(suppl 1):O1.
24. Roongpisuthipong A, Siriwasin W, Simonds RJ, et al. HIV seroconversion during pregnancy and risk for mother-to-infant transmission. J Acquir Immun Defic Syndr. 2001;26:348-351. (Pubitemid 32436000)
25. Colebunders R, Kapita B, Nekwei W, et al. Breastfeeding and transmission of HIV. Lancet. 1988;2:1487. (Pubitemid 19016671)
26. Palasanthiran P, Ziegler JB, Stewart GJ, et al. Breast-feeding during primary maternal human immunodeficiency virus infection and risk of transmission from mother to infant. J Infect Dis. 1993;167:441-444. (Pubitemid 23036448)
27. Hira SK, Mangrola UG, Mwale C, et al. Apparent vertical transmission of human immunodeficiency virus type 1 by breast-feeding in Zambia. J Pediatr. 1990;117:421-424. (Pubitemid 20315665)
28. Van de Perre P, Simonon A, Msellati P, et al. Postnatal transmission of human immunodeficiency virus type 1 from mother to infant. N Engl J Med. 1991;325:593-598.
29. Embree JE, Njenga S, Datta P, et al. Risk factors for postnatal motherchild transmission of HIV-1. AIDS. 2000;14:2535-2541.
30. Liang K, Gui X, Zhang YZ, et al. A case series of 104 women infected with HIV-1 via blood transfusion postnatally: high rate of HIV-1 transmission to infants through breast-feeding. J Infect Dis. 2009;200:682-686.
31. Humphrey JH, Marinda E, Mutasa K, et al. Mother to child transmission of HIV among Zimbabwean women who seroconverted postnatally: prospective cohort study. BMJ. 2010;341:c6580.
32. Rollins N, Little K, Mzolo S, et al. Surveillance of mother-to-child transmission prevention programmes at immunization clinics: the case for universal screening. AIDS. 2007;21:1341-1347. (Pubitemid 46883489)
33. Rollins N, Mzolo S, Moodley T, et al. Universal HIV testing of infants at immunization clinics: an acceptable and feasible approach for early infant diagnosis in high HIV prevalence settings. AIDS. 2009;23:1851-1857.
34. Bland RM, Rollins NC, Coutsoudis A, et al. Breastfeeding practices in an area of high HIV prevalence in rural South Africa. Acta Paediatr. 2002; 91:704-711. (Pubitemid 34779335)
35. Department of Health. Clinical Guidelines: PMTCT (Prevention of Mother-to-Child Transmission). 2010. Available at: http://www.rhru.co.za/ Resources/Documents/2010%20PMTCT%20Guidelines.pdf. AccessedJanuary 6, 2012.
36. Department of Health. Policy and Guidelines for the Implementation of the PMTCT programme. 2008. Available at: http://www.doh.gov.za/docs/policy/2008/ pmtct.pdf. Accessed January 6, 2012.
37. Moodley D, Moodley J, Coovadia H, et al. A multicenter randomized controlled trial of nevirapine versus a combination of zidovudine and lamivudine to reduce intrapartum and early postpartum mother-to-child transmission of human immunodeficiency virus type 1. J Infect Dis. 2003;187:725-735. (Pubitemid 36286932)
38. Doherty T, Besser M, Donohue S, et al. An Evaluation of the Prevention of Mother-to-child Transmission (PMTCT) of HIV Initiative in South Africa: Lessons and Key Recommendations. Durban, South Africa: Health Systems Trust; 2003. Available at: http://www.hst.org.za/sites/default/files/pmtct-national.pdf. Accessed July 28, 2011.
39. Coutsoudis A, Pillay K, Kuhn L, et al. Method of feeding and transmission of HIV-1 from mothers to children by 15 months of age: prospective cohort study from Durban, South Africa. AIDS. 2001;15:379-387. (Pubitemid 32163824)
40. Goga AE, Van Wyk B, Doherty T, et al. Operational effectiveness of guidelines on complete breast-feeding cessation to reduce mother-tochild transmission of HIV: results from a prospective observational cohort study at routine prevention of mother-to-child transmission sites, South Africa. J Acquir Immun Defic Syndr. 2009;50:521-528.
41. Doherty T, Chopra M, Jackson D, et al. Effectiveness of the WHO/UNICEF guidelines on infant feeding for HIV-positive women: results from a prospective cohort study in South Africa. AIDS. 2007;21:1791-1797. (Pubitemid 47237567)
42. Johnson LF. A Model of Paediatric HIV in South Africa. Centre for Infectious Disease Epidemiology and Research. Cape Town, South Africa: University of Cape Town; 2010. Available at: http://webdav.uct.ac.za/depts/epi/ publications/documents/Paediatric-HIV-modelling5.pdf.Accessed February 23, 2011.
43. Stringer EM, Ekouevi DK, Coetzee D, et al. Coverage of nevirapinebased services to prevent mother-to-child HIV transmission in 4 African countries. JAMA. 2010;304:293-302.
44. Sherman GG, Jones SA, Coovadia AH, et al. PMTCT from research to reality-results from a routine service. S Afr Med J. 2004;94:289-292. (Pubitemid 38585224)
45. Nkonki LL, Doherty TM, Hill Z, et al. Missed opportunities for participation in prevention of mother to child transmission programmes: simplicity of nevirapine does not necessarily lead to optimal uptake, a qualitative study. AIDS Res Ther. 2007;4:27.
46. Leroy V, Sakarovitch C, Cortina-Borja M, et al. Is there a difference in the efficacy of peripartum antiretroviral regimens in reducing motherto-child transmission of HIV in Africa? AIDS. 2005;19:1865-1875. (Pubitemid 41546606)
47. Dabis F, Bequet L, Ekouevi DK, et al. Field efficacy of zidovudine, lamivudine and single-dose nevirapine to prevent peripartum HIV transmission. AIDS. 2005;19:309-318. (Pubitemid 40396563)
48. Lallemant M, Jourdain G, Le Coeur S, et al. Single-dose perinatal nevirapine plus standard zidovudine to prevent mother-to-child transmission of HIV-1 in Thailand. N Engl J Med. 2004;351:217-228.
49. Tonwe-Gold B, Ekouevi DK, Viho I, et al. Antiretroviral treatment and prevention of peripartum and postnatal HIV transmission in West Africa: evaluation of a two-tiered approach. PLoS Med. 2007;4:e257.
50. Peltier CA, Ndayisaba GF, Lepage P, et al. Breastfeeding with maternal antiretroviral therapy or formula feeding to prevent HIV postnatal mother-to-child transmission in Rwanda. AIDS. 2009;23:2415-2423.
51. Palombi L, Marazzi MC, Voetberg A, et al. Treatment acceleration program and the experience of the DREAM program in prevention of mother-to-child transmission of HIV. AIDS. 2007;21(suppl 4):S65-S71. (Pubitemid 47051751)
52. Hoffman RM, Black V, Technau K, et al. Effects of highly active antiretroviral therapy duration and regimen on risk for mother-to-child transmission of HIV in Johannesburg, South Africa. J Acquir Immun Defic Syndr. 2010;54:35-41.
53. Breastfeeding and HIV International Transmission Study Group. Late postnatal transmission of HIV-1 in breast-fed children: an individual patient data meta-analysis. J Infect Dis. 2004;189:2154-2166.
54. Coovadia HM, Rollins NC, Bland RM, et al. Mother-to-child transmission of HIV-1 infection during exclusive breastfeeding in the first 6 months of life: an intervention cohort study. Lancet. 2007;369:1107-1116. (Pubitemid 46483637)
55. Becquet R, Bland R, Leroy V, et al. Duration, pattern of breastfeeding and postnatal transmission of HIV: pooled analysis of individual data from West and South African cohorts. PLoS One. 2009;4:e7397.
56. Kumwenda NI, Hoover DR, Mofenson LM, et al. Extended antiretroviral prophylaxis to reduce breast-milk HIV-1 transmission. N Engl J Med. 2008;359:119-129. (Pubitemid 351962035)
57. Chasela CS, HudgensMG, Jamieson DJ, et al.Maternal or infant antiretroviral drugs to reduce HIV-1 transmission. N Engl J Med. 2010;362:2271-2281.
58. Six Week Extended-dose Nevirapine Study Team. Extended-dose nevirapine to 6 weeks of age for infants to prevent HIV transmission via breastfeeding in Ethiopia, India, and Uganda: an analysis of three randomised controlled trials. Lancet. 2008;372:300-313.
59. Taha TE, Kumwenda J, Cole SR, et al. Postnatal HIV-1 transmission after cessation of infant extended antiretroviral prophylaxis and effect of maternal highly active antiretroviral therapy. J Infect Dis. 2009;200:1490-1497.
60. Shisana O, Rehle T, Simbayi LC, et al. South African National HIV Prevalence, HIV Incidence, Behaviours and Communication Survey, 2005. Cape Town, South Africa: HSRC Press; 2005. Available at:http://www.hsrcpress.ac.za.
61. Shisana O, Simbayi LC, Rehle T, et al. South African National HIV Prevalence, Incidence, Behaviour and Communication Survey, 2008:The Health of Our Children. 2010. Available at: http://www.hsrc.ac.za/Research-Publication- 21767.phtml. Accessed August 7, 2010.
62. Raftery AE, Bao L. Estimating and projecting trends in HIV/AIDS generalized epidemics using Incremental Mixture Importance Sampling. Biometrics. 2010;66:1162-1173.
63. Department of Health. HIV and AIDS and STI Strategic Plan for South Africa, 2007-2011. 2007. Available at: http://www.doh.gov.za/docs/strategicplan/ 2007/part1.pdf. Accessed January 6, 2012.
64. Mahy M, Stover J, Kiragu K, et al. What will it take to achieve virtual elimination of mother-to-child transmission of HIV? An assessment of current progress and future needs. Sex Transm Infect. 2010;86(suppl 2):ii48-ii55.
65. Weinhardt LS, Carey MP, Johnson BT, et al. Effects of HIV counseling and testing on sexual risk behavior: a meta-analytic review of published research, 1985-1997. Am J Public Health. 1999;89:1397-1405. (Pubitemid 29404565)
66. Denison JA, O'Reilly KR, Schmid GP, et al. HIV voluntary counseling and testing and behavioral risk reduction in developing countries: a metaanalysis, 1990-2005. AIDS Behav. 2008;12:363-373.
67. Musiime V, Ssali F, Kizito H, et al. Need for review of prevention of mother-to-child transmission practice especially in discordant couples: a case of mother-to-child transmission of HIV during breast feeding by a mother who tested HIV negative antenatally. AIDS. 2007;21:1658-1659. (Pubitemid 47075494)
68. Aluisio A, Richardson BA, Bosire R, et al. Male antenatal attendance and HIV testing are associated with decreased infant HIV infection and increased HIV-free survival. J Acquir Immun Defic Syndr. 2011;56:76-82.
69. Msuya SE, Mbizvo EM, Hussain A, et al. Low male partner participation in antenatal HIV counselling and testing in northern Tanzania: implications for preventive programs. AIDS Care. 2008;20:700-709. (Pubitemid 351913396)
70. Katz DA, Kiarie JN, John-Stewart GC, et al. Male perspectives on incorporating men into antenatal HIV counseling and testing. PLoS One. 2009;4:e7602.
71. Abdool Karim Q, Abdool Karim SS, Frohlich JA, et al. Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science. 2010;329:1168-1174.
72. Baeten J, Celum C. Antiretroviral pre-exposure prophylaxis for HIV-1 prevention among heterosexual African men and women: the Partners PrEP Study [Abstract MOAX0106]. Presented at: 6th International AIDS Society Conference; July 17-20, 2011; Rome, Italy.
73. Thigpen MC, Kebaabetswe PM, Smith DK, et al. Daily oral antiretroviral use for the prevention of HIV infection in heterosexually active young adults in Botswana: results from the TDF2 study [Abstract WELBC01]. Presented at: 6th International AIDS Society Conference; July 17-20, 2011; Rome, Italy.
74. Foster C, Lyall H, Olmscheid B, et al. Tenofovir disoproxil fumarate in pregnancy and prevention of mother-to-child transmission of HIV-1: is it time to move on from zidovudine? HIV Med. 2009;10:397-406.
75. Gray RH, Li X, Kigozi G, et al. Increased risk of incident HIV during pregnancy in Rakai, Uganda: a prospective study. Lancet. 2005;366: 1182-1188. (Pubitemid 41393596)
76. Taha TE, Hoover DR, Dallabetta GA, et al. Bacterial vaginosis and disturbances of vaginal flora: association with increased acquisition of HIV. AIDS. 1998;12:1699-1706. (Pubitemid 28418342)
77. Mugo NR, Heffron R, Donnell D, et al. Increased risk of HIV-1 transmission in pregnancy: a prospective study among African HIV- 1-serodiscordant couples. AIDS. 2011;25:1887-1895.
78. Leroy V, Van de Perre P, Lepage P, et al. Seroincidence of HIV-1 infection in African women of reproductive age: a prospective cohort study in Kigali, Rwanda, 1988-1992. AIDS. 1994;8:983-986. (Pubitemid 24206610)
79. Munjoma MW, Mhlanga FG, Mapingure MP, et al. The incidence of HIV among women recruited during late pregnancy and followed up for six years after childbirth in Zimbabwe. BMC Public Health. 2010;10:668.
80. Morrison CS, Wang J, Van Der Pol B, et al. Pregnancy and the risk of HIV-1 acquisition among women in Uganda and Zimbabwe. AIDS. 2007;21:1027-1034. (Pubitemid 46684334)
81. Rehle TM, Hallett TB, Shisana O, et al. A decline in new HIV infections in South Africa: estimating HIV incidence from three national HIV surveys in 2002, 2005 and 2008. PLoS One. 2010;5:e11094.
82. Department of Health. South Africa Demographic and Health Survey 2003: Preliminary Report. Pretoria, South Africa, 2004; Available at:http://www.doh. gov.za/docs/reports/2003/sadhs2003/part2.pdf. AccessedJanuary 6, 2012.
83. Goga A, Lombard C, Dinh T, et al. Impact of the national prevention of mother-to-child transmission (PMTCT) programme on mother-to-child transmission of HIV (MTCT), South Africa, 2011 [Abstract 675]. Presented at: 5th South African AIDS Conference; June 7-10, 2011; Durban, South Africa.